HTG Molecular Diagnostics, Inc.
HTGMQ
$0.0001
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.03M | 2.44M | 1.25M | 1.49M | 1.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03M | 2.44M | 1.25M | 1.49M | 1.18M |
| Cost of Revenue | 2.76M | 3.58M | 2.14M | 2.86M | 2.78M |
| Gross Profit | -1.73M | -1.14M | -891.20K | -1.37M | -1.59M |
| SG&A Expenses | 3.28M | 3.47M | 3.40M | 4.31M | 4.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.05M | 7.09M | 5.60M | 7.17M | 7.44M |
| Operating Income | -5.01M | -4.65M | -4.35M | -5.68M | -6.25M |
| Income Before Tax | -5.05M | -4.69M | -4.51M | -5.88M | -6.50M |
| Income Tax Expenses | 2.20K | 4.00K | 1.60K | 4.90K | 400.00 |
| Earnings from Continuing Operations | -5.05M | -4.69M | -4.52M | -5.89M | -6.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.05M | -4.69M | -4.52M | -5.89M | -6.50M |
| EBIT | -5.01M | -4.65M | -4.35M | -5.68M | -6.25M |
| EBITDA | -4.93M | -4.55M | -4.21M | -5.51M | -6.07M |
| EPS Basic | -2.28 | -4.47 | -4.91 | -6.42 | -9.73 |
| Normalized Basic EPS | -1.43 | -2.86 | -3.06 | -4.01 | -6.08 |
| EPS Diluted | -2.28 | -4.47 | -4.91 | -6.42 | -9.73 |
| Normalized Diluted EPS | -1.43 | -2.86 | -3.06 | -4.01 | -6.08 |
| Average Basic Shares Outstanding | 2.21M | 1.05M | 920.70K | 916.90K | 667.60K |
| Average Diluted Shares Outstanding | 2.21M | 1.05M | 920.70K | 916.90K | 667.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
